Prothena Corporation plc
PRTA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.05 | -0.01 | -0.75 | 1.77 |
| FCF Yield | -7.72% | -14.21% | -8.01% | -6.42% |
| EV / EBITDA | -5.67 | 0.67 | -3.96 | -4.40 |
| Quality | ||||
| ROIC | -13.23% | -25.33% | -14.31% | -12.61% |
| Gross Margin | -1,098.26% | 100.00% | 100.00% | 100.00% |
| Cash Conversion Ratio | 1.11 | 0.37 | 0.89 | 0.82 |
| Growth | ||||
| Revenue 3-Year CAGR | -56.27% | -43.60% | 35.93% | 35.85% |
| Free Cash Flow Growth | 12.60% | 13.07% | -11.69% | -5.80% |
| Safety | ||||
| Net Debt / EBITDA | 8.95 | 6.98 | 6.24 | 7.12 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -32.67 | 0.00 | 0.00 | 0.00 |